At the Conference on Retroviruses and Opportunistic Infections (CROI 2026) held in Denver last week, Dr Sari Reisner from the University of Michigan presented data on how many transgender women in a national US cohort acquired HIV over a two-year period, and the factors associated with getting HIV. “Our study found that HIV incidence remains high among trans women in the US and that disparities persist across race and ethnicity, with highest HIV incidence for Black, Latina and Asian trans women,” Reisner stated.

At the recent Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver, US, the use of an app for men with HIV who also use illicit stimulants led to 58% lower odds of having a detectable viral load after six months, when compared to a control group who did not use the app in a fully remote randomised controlled trial.

Peter Staley’s talk at the opening session of the Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver was a grim post-mortem of one of the most challenging years in recent HIV history – an ‘annus horribilis’ – a phrase Queen Elizabeth II used to describe 1992 and The Lancet applied to 2025.

Garnering a standing ovation at IAS 2025, Sameer Sah, from Medical Aid for Palestinians, provided a devastating first-hand account of what’s been happening for nearly two years in Gazan healthcare set...

One year ago, UNAIDS announced that the HIV response was at a critical crossroads. Apart from a handful of countries, the world was not on track to meet the ambitious 2030 goals: 95% of those wit...

Experts share what they’re eager to discuss and learn about at a major research meeting in Kigali, Rwanda: a focus on Africa, devastating funding cuts, and the latest HIV science.

Experts share what they’re eager to discuss and learn about at a major research meeting in Kigali, Rwanda: a focus on Africa, devastating funding cuts, and the latest HIV science.

Multiple strategies exist to prevent getting HIV. Navigating this landscape involves numerous choices and considerations that clinicians should be aware of.